Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2015

View Archived Issues

Recardio secures financing to advance dutogliptin in acute myocardial infarction

Three-party collaboration to explore combination of Lynparza and CRLX-101

Ludwig Cancer Research and Cancer Research Institute partner with Targovax

Turing and University of Toledo sign research agreement for Canavan disease

Otonomy begins enrollment in phase III trial of OTO-104 in Meniere's disease

Lilly initiates phase I study of LY-3127804 with ramucirumab for advanced solid tumors

Prima BioMed plans trial combining IMP-321 and immune checkpoint inhibitor

LP-226-A-1 shows efficacy in mouse models of Alzheimer's disease

Head and neck cancer results reported for dovitinib trial in genomically selected patients

Crizotinib increases PFS in previously untreated East Asian patients with NSCLC

Oncolytics Biotech starts phase Ib trial of Reolysin, bortezomib and dexamethasone in MM

LPAR1 antagonist tested in mouse NASH model

OCZ-103: oral pentamidine for alcoholic liver disease

Oncolytic viral immunotherapy HF-10 active in trials in patients with superficial cancers

Oragenics completes pre-IND meeting for OG-253

Aduro Biotech files IND application for ADU-741

Vitae releases topline results from multiple-ascending-dose phase I trial of VTP-43742

AstraZeneca's lung cancer drug Tagrisso available in the U.S.

Merck KGaA completes acquisition of Sigma-Aldrich

Imperial Innovations Group discloses anthrax vaccine

Medicinal Chemistry Pharmaceuticals patents anti-MUC-1 antibody

Rgenix divulges creatine transport inhibitors

Novartis reports TLR7 agonists

AbMax Biotechnology introduces anti-HER2 antibodies

The Catholic University of Korea presents cytokine production inhibitors

Kyprolis approved in E.U. for multiple myeloma

FDA advisory committee votes against MCNA for non-muscle invasive bladder cancer

Orkambi approved in E.U. for cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.